Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies

Teresa Rodriguez Martin, Mariano A Garcia-Blanco, S Gary Mansfield, Andrew C Grover, Michael Hutton, Qingming Yu, Jianhua Zhou, Brian H Anderton, Jean-Marc Gallo

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)


Frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) is caused by mutations in the gene encoding the microtubule-associated protein, tau. Some FTDP-17 mutations affect exon 10 splicing. To correct aberrant exon 10 splicing while retaining endogenous transcriptional control, we evaluated the feasibility of using spliceosome-mediated RNA trans-splicing (SMaRT) to reprogram tau mRNA. We designed a pre-trans-splicing molecule containing human tau exons 10 to 13 and a binding domain complementary to the 3' end of tau intron 9. A minigene comprising tau exons 9, 10, and 11 and minimal flanking intronic sequences was used as a target. RT-PCR analysis of SH-SY5Y cells or COS cells cotransfected with a minigene and a pre-trans-splicing molecule using primers to opposite sides of the predicted splice junction generated products containing exons 9 to 13. Sequencing of the chimeric products showed that an exact exon 9-exon 10 junction had been created, thus demonstrating that tau RNA can be reprogrammed by trans-splicing. Furthermore, by using the same paradigm with a minigene containing full-length intronic sequences, we show that cis-splicing exclusion of exon 10 can be by-passed by trans-splicing and that conversion of exon 10(-) tau RNA into exon 10(+) tau RNA could be achieved with approximate to 34% efficiency. Our results demonstrate that an alternatively spliced exon can be replaced by trans-splicing and open the way to novel therapeutic applications of SMaRT for tauopathies and other disorders linked to aberrant alternative splicing.
Original languageEnglish
Pages (from-to)15659 - 15664
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number43
Publication statusPublished - 25 Oct 2005


  • Alternative Splicing
  • Animals
  • Base Sequence
  • COS Cells
  • Cell Line
  • Cercopithecus aethiops
  • Exons
  • Humans
  • Molecular Sequence Data
  • Neuroblastoma
  • Spliceosomes
  • Tauopathies
  • Trans-Splicing
  • tau Proteins


Dive into the research topics of 'Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies'. Together they form a unique fingerprint.

Cite this